Hypertrophic cardiomyopathy (HCM), a genetic form of heart disease with thick heart walls, is the most common cause of sudden death in patients under 50. While only a minority of patients with HCM are ...
Please provide your email address to receive an email when new articles are posted on . The following risk scores and recommendations for an ICD implant were compared: 2014 ESC risk scoring model, ...
Recently, the European Society of Cardiology published new guidelines advancing an equation as the best way to determine which hypertrophic cardiomyopathy patients should receive an implantable ...
The ESC Guidelines throw light on a new sudden death predictor for patients with hypertrophic cardiomyopathy (HCM) that also identifies candidates for implantable cardioverter defibrillators (ICDs).
Learn about sudden cardiac death risk in people with hypertrophic cardiomyopathy, including risk factors, prevention methods, ...
"Appropriately selected patients with NICM have the potential to benefit from primary prevention ICD therapy…Besides consideration of ICD placement, attention to guideline-directed medical therapy and ...
In a typical population of patients requiring implantable cardioverter-defibrillator (ICD) therapy without pacing, mostly for the primary prevention of sudden cardiac death, a subcutaneous ICD (S-ICD; ...
If you or a loved one has recently been diagnosed with hypertrophic cardiomyopathy (HCM), you may have questions about what it means for your health and how to manage the condition. Understanding ...